Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2009; 16(1): 19-24


The Approach to BIRADS 3 and 4 Breast Lesions: Which Lesions should be Biopsied?

Deniz Gazioğlu*, Oktay Büyükaşık*, A. Oğuz Hasdemir**, Hülagü Kargıcı*

.




Abstract


Introduction: The rate of breast cancer, the most common cancer in women, is increasing day by day. Nowadays for the early diagnosis of breast cancer, a common language is a necessity between concerned disciplines.In this case, we started to use the BIRADS lexicon in our country also.In this study we aim to share our clinical experience about BIRADS 3 and BIRADS 4 lesions.

Material and method: In this prospectively planned study, the patients who were examined between January 2005 and June 2008 in 2nd general surgery policlinic of Dışkapı Yıldırım Beyazıt Training and Research Hospital and classified as BIRADS 3 and 4 after breast USG and mammography were included.

Findings: The median age was 42.8 (18-76). Our average follow up time was 19 months.While 1 of 48 BIRADS 3 classified patients was found malignant (2.1%), the 22 of 49 BIRADS 4 classified patients were malignant (44.8%). BIRADS 4 lesions’ rate increased parallel to the increase in age. Considering pathologic data, BIRADS lexicon was 95.7% sensitive and 63.5% spesific.

Conclusion: Despite the variable results, the malignancy rates of BIRADS 3 and 4 lesions were 2-11% and 25-67%. Our results were similar to the ones in the literature and the difference between groups was statistically significant. BIRADS 3 lesions can be followed up once in every 6 months periods because of low cancer risks. But BIRADS 4 lesions should be biopsied with an appropriate method since half of them were malignant.

Key Words: BIRADS 3 and 4 Breast Lesions, Breast Cancer






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.